COMPARISON OF ANALGESIC EFFICACY OF ANTIEPILEPTIC GABAPENTIN WITH CONVENTIONAL ANALGESIC DICLOFENAC IN RAT EXPERIMENTAL MODELS by Kansal, Saurabh et al.
Kansal et al                                              Journal of Drug Delivery & Therapeutics. 2017; 7(1):44-48                                        44 
© 2011-16, JDDT. All Rights Reserved                                     ISSN: 2250-1177                                     CODEN (USA): JDDTAO 
Available online on 15.01.2017 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open access to Pharmaceutical and Medical research 
© 2016, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
noncommercial use, provided the original work is properly cited 
 
Research Article 
COMPARISON OF ANALGESIC EFFICACY OF ANTIEPILEPTIC 
GABAPENTIN WITH CONVENTIONAL ANALGESIC DICLOFENAC IN 
RAT EXPERIMENTAL MODELS     
Saurabh Kansal
1
, Priti Sinha
2
, Ruchika Agarwal
3
, Vatsala Sharma
4
 
1Department of pharmacology, Subharti medical college, Meerut, India 
2Department of anatomy, Subharti medical college, Meerut, India 
3Department of physiology, Subharti medical college, Meerut, India 
4Department of paediatrics, Subharti medical college, Meerut, India 
 
ABSTRACT 
Some Antiepileptic drugs have been shown to be clinically efficacious in the treatment of neuropathic pain and are being used by the 
clinician. This study determined the analgesic effect of gabapentin (A novel Anticonvulsant) in rats in different types of acute and 
chronic nociceptive test like Tail flick and Formalin test & compared its potency with a conventional nonopioid analgesic diclofenac. 
Peroral administration of gabapentin produced no any marked effect on early phase response of formalin test but significantly 
suppressed the late phase response. In tail flick test gabapentin produced no any significant analgesic effect while diclofenac 
produced a significant reduction of pain in tail flick test as well as in both phases of the formalin test. Thus we have observed that 
gabapentin produced antinociception in chronic pain as the second phase of formalin test reflects chronic inflammatory pain while 
diclofenac produced both acute and chronic type of antinociceptive effect as it significantly suppressed the pain in both tail-flick and 
formalin test. 
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INTRODUCTION 
Pain as a sensation and feeling, is a known entity from 
antiquity. According to the IASP-                                                                       
“pain  is  an  unpleasant,  sensory  and  emotional  
experience  associated  with  actual  or   potential  tissue  
damage  or  described  in  terms  of  such  damage” 1.         
Pain could be acute or chronicin nature. Acute  pain  is  
short  lasing  and  easy  to  manage  while  chronic  pain  
is  that  pain  which  persists  beyond  the  usual  course  
of  injury  or  diseases,  or  reoccurs  in  every  few  
months  or  years. Pathologically chronic pain state 
could be inflammatory or neuropathic. Inflammatory  
pain  is  due  to  chronic  inflammation  that  is  
increased  by  pressure,  but  neuropathic  pain  occurs  
due  to  involvement  in  alteration  in  nervous  system  
function  or  reorganization  of  nervous  system  
structure  and  are  non  adaptable. NSAIDs  and  
opioids  are  the  most  potent  and  commonly  used  
group  of  established  analgesic  drugs  in  treatment  of  
pain,  but  there  use  is  associated  with  a  greater  
degree  of  adverse  drug  reactions  and  abuse  liability
2
 
. 
The  anticonvulsants  carbamazepine  and  gabapentine  
are  now  established  drugs  for  trigeminal  neuralgia  
and  postoperative  pain  as  non  conventional  
analgesics
3
. Other  anticonvulsants  are  also  being  
tried  as  newer  unconventional  analgesic  drugs  that  
are  expanding  day  by  day. 
There  are  no  comparable  data  available,  whereby  
these  drugs  could  be  compared  simultaneously  for  
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their  analgesic  activity  in  suitable  animal  models  of  
acute  and  chronic  pain,  although  there  is  some  
consistency  in  their  effects  as  far  as  neuropathic  
animal  pain  models  are  concerned. 
So  the  present  study  was  planned  to  verify  the  
effects  of  novel  anticonvulsant  i.e  gabapentin  along   
in  common  acute  (  tail  flick  test )  and  chronic  
inflammatory (formalin test)  pain  models. Thus  we  
examined   the  antinociceptive   effect  of  gabapentin  
(a  newer  anticonvulsant)  in  animal  models  of  pain 
and  compared  its  antinociceptive  effects  also with  
conventional  nonopioid  analgesic  diclofenac. .  
MATERIALS AND METHOD 
This study has  been  carried  out  in  department  of  
pharmacology, HIMS, Dehradun  over  a  period  of  12  
months  for  evaluation  of  analgesic  effects  in  
animals. This study has been approved by ethical 
committee of HIMS.                                                                                                                                                                                                         
Animals used: A Adult  albino  rats  of  either  sex,  wt  
150-200gm  have  been  utilized  for  these  experiments. 
Drugs 
The  following  drugs  have  been  used  to  evaluate  
their  antinociceptive  effects  in  each  group  of  6  
animals,  given p.o. 1 hr before the experimentations.  
There  has  been  a  control  group  of  6  animals,  run  
simultaneously,  and  given  saline/vehicle  p.o. as per  
the  experiment.  All  the  experiment  was  done  at  the  
same  time in  the  morning  hours  on  all  days  of  
experimentation. 
Gabapentin
1
                                            50mg/kg 
Diclofenac
4
                                              5mg/kg 
Commercial preparations  of  these  drugs  have  been  
used. Gabapentin  (Sunpharma, Dadra,New Delhi)  and  
control drug  diclofenac  (Novaritis India Ltd. Pune,  
India) were  suspended  in  5%  acacia  and  double  
deionized  water. 
Both  drugs  were  administered  per  oral  by  gavage  in  
a  volume  of  1.0ml/kg  in  rats
5
. 
Procedures:  For antinociceptive evaluation 
6,7
 
Radiant heat method 
The  tail  flick  test  by  radiant  heat  method  using  
analgesiometer  was  carried  out  to  study  
antinociception.  Each  animal  was  placed  in  that  
manner  so  the  proximal  third  of  the  tail  of  the  
animal  was  laid  across  nicrome  wire  coil,  which  
was  heated  by  the  passage  of  an  electric  current.  
For  about  6  seconds  the  reaction  of  the  animal  has  
been  observed.  Rats  with  reaction  time  for  more  
than  6  seconds  have  not  been  used  in  the  test.  The 
tests compounds have been administerd per orally.  The  
animals  have  been  subjected  to  the  same  testing  
procedure  after  o,  60,  90,  and  eventually  120  
minutes  for  each  individual  animal.  The cut off time 
has been 10 seconds.  
Formalin Test 
The  formalin  test  has  been  used  as  the  model  of  
chronic  inflammatory  pain.  Formalin  has  been  
characterized  by  the  occurrence  of  two  characteristic  
phases  of  increased  pain  sensitivity  in  rats.  The  first  
phase  was  of  0-15  minutes  and  phase  2  was  of  45-
75  minutes.  Rat  has  been  administered  0.05ml  of  
10%  formalin  into  the  dorsal  portion  of  the  front  
paw.  The  test  drugs  has  been  administered  orally  
and  scored  according  to  a  pain  scale.  Pain  has  been  
quantified  by  counting  the  incidence  of  spontaneous  
flinches,  shakes  and  jerks  of  the  formalin  injected  
paw.  Analgesic  response  or  protection  has been  
indicated  if  both  paws  are  resting  on  floor  with  no  
obvious  favoring  of  injected  paw. 
Treatment  group  was  compared  with  appropriate  
control  groups  using “ student  t  test 
RESULTS 
The  present  study  was  conducted in the
Department  of  Pharmacology,  Himalayan  Institute  of  
Medical  Sciences,  Swami  Ram  Nagar,  Dehradun  
with  the  objective  to  experimentally  evaluate  the  
analgesic  effect of novel  antiepileptic  gabapentin and  
one analgesic  as positive  control  i.e  diclofenac. 
For this purpose, the following nociceptive experimental 
models were used. 
 Tail flick Test (by radiant heat metod)  
 Formalin test 
For  each  set  of  experiment, six  adult  healthy Albino  
rats  of  either  sex  each  were  used  for  both  
experimental  drugs. Gabapentin  (50  mg/kg  p.o.) and 
diclofenac (5mg/kg)  given  I   hr  before  the  
experimentations. 
Radiant Heat Test [table 1 & fig 1]    
During  the  evaluation  of  antinociceptive  effect  in  
tail  flick  radiant  heat  test ,  only  diclofenac  produced  
significant  increase  in  post  drug  latency  at   120  
mins  after  drug  administration 
Experimental  antiepileptic  drug  gabapentin  did  not  
change  tail  flick  latency  over  a  period  of  120  min  
after  administration  of  drug. 
Formalin test [table 2 & fig 2] 
The  formalin  test  has  been  used  as  a  model  of  
tonic  and  inflammatory  pain.  Formalin  has  been  
characterized  by  two  characteristic  phases  of  
increased  pain  sensitivity  in  rats.  The  first  phase  is  
of  0-15  minutes  denoting  acute  pain  and  phase  2  is  
of  45-75  minutes  denoting  chronic  inflammatory  
pain.  Number  of  raising  foot  (LR)  licking  and  
biting  (LB)  were  measured  for  the  two  phases  as  
end  points. 
In  the  first  phase  of  leg  raising  (LR)    formalin  test,    
positive  control  diclofenac  produced  significant  
decrease  in  leg  raising  (p<.05),  ot  experimental  
antiepileptic  drug  produced  no  any  significant  effect  
on  leg  raising  in  comparison  to  control  values. 
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In  the  first  phase  of  licking  and  biting   (LB),  
positive  control  (diclofenac)  again  produced  
significant  decrease  (p<0.02)  than  control  values  
while gabapentin  had  no effect. 
In  the  second  phase  of  raising  foot  (LR)  both 
diclofenac & gabapentin  produced  significant  decrease  
(p<0.05)  as  compared  to  control.  In the  licking  and  
biting  episodes  of  second  phase  also  gabapentin & 
diclofenac  exert  significant  effect  (p<0.02)  in  
comparison  to  control.  Decrease  observed  in  licking  
and  biting  (LB)  with  tramadol  was  more  (p=0.001)  
as  compared  to  control  values  than  with  
experimental  antiepileptic  drug  (p<0.02)  versus  
control  values.  
To  conclude,  the  present  study  investigated  
analgesic  property  of  gabapentin  in  both  animal  
models  of   pain.  Diclofenac found significantly 
effective in tail flick test. While  In  formalin test both 
diclofenac and gabapentin produced  significant  effect  
in  phase  2  of  formalin  test. 
    
Table 1: Effects of experimental drugs and positive controls (tramadol and diclofenac) on tail flick latency (in seconds) 
in radiant heat test over a period of 120 min of drugs/vehicle (NS) p.o administration in Albino rats 
Albino rats producing a reaction time of < 6 sec were selected for experiment and a cut off time of 10 sec was kept. 
Reading was taken at time interval 0, 60, 90 and 120 min after drug/vehicle administration. 
 Group No of Albino 
Rats 
Dose and Route of 
Administration of drugs 
Post Drug Latency (Mean±SE)  (in seconds) 
0 min 60 mins 90 mins 120 mins 
Control 6 0.09% p.o 5.08±0.24 5.13±0.23 5.15±0.18 5.17±0.15 
Tramadol 6 10 mg/kg p.o 5.23±0.24 5.40±0.22 5.53±0.21* 5.68±0.19*** 
Diclofenac 6 5 mg/kg p.o 5.15±0.26 5.30±0.25 5.42±0.25 5.55±0.23** 
Carbamazepine 6 30 mg/kg p.o 5.13±0.23 5.18±0.23 5.20±0.21 5.22±0.16 
Gabapentin 6 50 mg/kg p.o 5.15±0.24 5.20±0.22 5.22±0.18 5.28±0.14 
Lamotrigine 6 50 mg/kg p.o 5.10±0.38 5.15±0.37 5.17±0.41 5.18±0.41 
Levitiracetam  6 60 mg/kg p.o 5.12±0.23 5.17±0.22 5.18±0.18 5.20±0.14 
 * p < 0.05 vs control values at 0 min after tramadol p.o administration   
** p < 0.05 vs control values at 0 min after diclofenac p.o administration   
*** p < 0.02 vs control values at 0 min after tramadol p.o administration   
 
Figure 1: Effects of experimental drugs and positive controls (tramadol and diclofenac) on tail flick latency (in seconds) 
in radiant heat test over a period of 120 min of drugs/vehicle (NS) p.o administration in Albino rats.  
Albino rats producing a reaction time of < 6 sec were selected for experiment and a cut off time of 10 sec was kept. Reading were 
taken at time interval 0, 60, 90 and 120 min after drug/vehicle administration. 
 
* p < 0.05 vs control values at 0 min after tramadol p.o administration   
** p < 0.05 vs control values at 0 min after diclofenac p.o administration   
*** p < 0.02 vs control values at 0 min after tramadol p.o administration   
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Table 2: Effects of drugs on acetic acid (0.55% given as .01ml/gm i.p) induced visceral nociception in albino mice.  
All test drugs was administered 1 hr before giving acetic acid (i.p) in mice, abdominal contractions (writhes) were 
recorded after 5 min of injected acetic acid till 30 min. 
Group Dose and Route of Administration of drugs No. of Albino Mice No. of Writhes 
Mean ± SE 
Control (NS) 0.09% p.o 6 40.00 ± 1.81 
Tramadol 5 mg/kg p.o 6 28.00** ± 1.80 
Diclofenac 10 mg/kg p.o 6 32.33** ± 1.59 
Carbamazepine 30 mg/kg p.o 6 35.33 ± 1.34 
Gabapentin 50 mg/kg p.o 6 37.33 ± 1.48 
Lamotrigine 50 mg/kg p.o 6 38.17 ± 0.91 
Levitiracetam 60 mg/kg p.o 6 39.67 ± 1.59 
** p < 0.01 vs. control values 
Figure 2: Effects of drugs on acetic acid (0.55% given as .01ml/gm i.p) induced visceral nociception in albino mice.  
All test drugs was administered 1 hr before giving acetic acid (i.p) in mice, abdominal contractions (writhes) were 
recorded after 5 min of injected acetic acid till 30 min. 
 
** p < 0.01 vs. control value 
 
DISCUSSION 
The  present  study  was  done  to  evaluate  the  
antinociceptive  effect   of  novel  antiepileptic  
gabapentin   on  different  acute  animal  pain  models  
i.e.  phasic  pain  model  (tail  flick  by  radiant  heat  
method)  and  tonic  inflammatory  pain  model  
(formalin  test)  with  the  help  of  conventional  
analgesic  drugs  i.e. diclofenac  which  was  used  as  
positive  control  in  rats. 
Diclofenac  is  well  established  analgesic  drug  that  
showed  significant  antinociceptive  effect  in  tail  flick  
test  when  given  orally  (5  mg/kg)  in  present  study  
at  120  min.  It  is  in  conformity  with  previous  
studies  of  diclofenac  in  which  diclofenac  showed  
analgesic  effect  in  tail  flick  test  while  given 0.001-
10.0 mg/kg ,body  weight i.p 
8
; 5 mg/kg, i.v. 
9
 ,1-50 
microgm, i.c.v, 0.9-10 microgm , i.t.
4
.   
In  formalin  test  ,diclofenac  presently  produced  
significant  analgesic  effect  in  both  phase  1  &  phase  
2  pain  which  confirms  to  an  earlier  study  in  which  
diclofenac  at  a  dose  of  5,  10 & 20 mg/kg,  i.p.  
produced  significant  antinociceptive  effect  in  both  
phases  of  formalin  test 
10
. Furthermore,  diclofenac,  
5mg/kg,  i.v.  had  produced  analgesic  effect  alone  or  
in  combination  with  opioid 
4
  and  pretreatment  with  
local  diclofenac,  25-200  mg/paw  in  formalin  test 
11
  
in  the  past.   
In  our  study  in  tail  flick  test  no  significant  
antinociceptive  effect  has  been  observed  with  
gabapentin 50 mg/kg.  This  is  in  conformity  with    
earlier  studies  in  which  gabapentin,  300 microgram,  
i.t. (12) and  300  microgram  i.c.v  
13
  produced  no  
significant  effect  in  tail  flick  test. 
In formalin test, in present study gabapentin, 50mg/kg, 
p.o.  produced  significant  effect  in  phase  2  but  not  
in  phase  1  which  is  very  similar  to  previous  study  
in  which  gabapentin,  300 microgram i.t  inhibited  
second  phase  flinching  behavior   significantly  but  
not  in  phase  one
14
.  In  another  study gabapentin  
when  given  intraplantarly  with  either  6/60 mcg  had  
significantly  reduced  flinching  behavior  during  phase  
2,  however  phase  1  flinching  behavior  was  
unaffected
15
. Gabapentin  in  formalin  test  had  
produced  a  dose  related  inhibition  of  phase  2  with  
ED50  values  of  22.9 mg/kg,  i.p,  but  not  of  phase  1  
16
  and  it  is  also  reported  that  gabapentin,  30mg/kg,  
s.c.  &  100  mg/kg,  s.c.  inhibited  the  late  phases  of  
nociceptive  responses
17,18
  supporting  present  findings.                                             
The  first  and  second  phase  of  formalin  test  are  
generally  believed  to  reflect  excitation  of  peripheral  
afferent  nociceptors  and  central  sensitization,  
respectively  
19
.consistant  with  previous  reports  
20
  
gabapentin  was  found  to  attenuate  second  phase  
nociceptive  behavior  in  the  present  study,  suggesting  
a  specific  inhibition  of  central  sensitization  with  
alpha 2  delta  binding  
21
  in  central  neural  axis  of  
pain. 
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CONCLUSION 
Evaluation  of  antinociception  in  acute  and  chronic  
pain  models   was    done   with  the  help  of  standard  
method  of  Tail  flick  and  formalin  test  in  Albino  
rats  of  either  sex  on  novel  anticonvulsant  
gabapentin. Diclofenac was used as positive control. 
Diclofenac as positive control was effective in both pain 
models. In  tail  fick  test,  which  is  the  model  of  
phasic  pain  using  thermal  stimuli  with  the  help  of  
hot  nichrome  wire,  gabapentin  did  not  produce  any  
significant  antinociceptive  effect. In    formalin  test,   
both  the  test  drugs  did  not  produce  any  significant  
effect   on  phase  1  denoting  acute  pain  while  in  2  
phase  which  denotes  prolonged  inflammatory  pain,  
gabapentin  and  diclofenac  both  produced  significant  
antinociceptive  effect. Based  on  the  present  study  it  
is  concluded  that  newer   anticonvulsant  gabapentin,  
produces  effects  in  chronic  inflammatory  pain  
models  but  does  not  affect  acute  nociception  in  
animals.  As  formalin  phase  2  chronic  pain  was  
relieved  by  both  diclofenac and  gabapentin. 
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ABBREVIATIONS 
p.o  : per oral 
s.c  : subcutaneous  
i.m  : intramuscular  
i.v  : intravenous  
i.p  : intraperitoneal  
i.c.v  : intracerebro ventricular  
i.t  : intrathecal  
NS  : normal saline  
LR  : leg raising  
LB  : licking and biting  
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